PTC Therapeutics: Pay

PTC Therapeutics paid its 2 named executives $6.7M in total in FY2025 (Dec).

Pay$100 in the stock at the end of FY21 → $113
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Matthew B. KleinChief Executive Officer
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
3 years
Eric PauwelsChief Business Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Neil AlmsteadChief Technical Operations Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)Not disclosed
FY2022 (Dec)Not disclosed
4 years
Lee GoldenExecutive Vice President and Chief Medical Officer
FY2024 (Dec)
FY2023 (Dec)
2 years
Pierre GravierChief Financial Officer
FY2024 (Dec)
FY2023 (Dec)
2 years

CEO pay against the pay peers

In FY2024 (Dec), the median CEO pay of the 8 peers with pay on file was $13.2M. The CEO of PTC Therapeutics was paid $7.4M, 44% below the median.

  1. 1Supernus Pharmaceuticals
  2. 2Jazz Pharmaceuticals
  3. 3Ionis Pharmaceuticals
  4. 4Ultragenyx Pharmaceutical
  5. 5Halozyme Therapeutics
  6. 6INSMED
  7. 7Alkermes plc.
  8. 8Acadia Pharmaceuticals
  9. 9PTC Therapeutics
  10. 10Amicus Therapeutics, Inc.Not disclosed
  11. 11Apellis Pharmaceuticals, Inc.Not disclosed
  12. 12Blueprint Medicines Corp.Not disclosed
  13. 13Corcept TherapeuticsNot disclosed
  14. 14ExelixisNot disclosed
  15. 15Intra-Cellular Therapies, Inc.Not disclosed
  16. 16Pacira BioSciences, Inc.Not disclosed
  17. 17Sarepta Therapeutics, Inc.Not disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.